Clinical Trial Update: Monitoring Arrhythmia Patients (IMPACT)

View source ↗

Summary

The IMPACT trial, sponsored by Corventis, has completed a study evaluating monitoring for patients with cardiac arrhythmias.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia

Snippet

Sponsor: Corventis, Inc. | Conditions: Arrhythmias | Status: COMPLETED